Results for influenzae translation from English to Croatian

haemophilus influenzae type b polysaccharide conjugated to tetanus protein
polisaharid bakterije haemophilus influenzae tip b

as for macrolides, h. influenzae is classified as intermediately susceptible.
h. influenzae je klasificiran kao umjereno osjetljiv na makrolide.

haemophilus influenzae type b polysaccharide 3 µg conjugated to meningococcal protein 50 µg
polisaharid bakterije haemophilus influenzae tip b 3 µg konjugiran s meningokoknim proteinom 50 µg

1the correlation between macrolide mics and clinical outcome is weak for h. influenzae.
1kod h. influenzae je korelacija između mik-a makrolida i kliničkog ishoda slaba.

this should be taken into account when treating infections caused by h. influenzae.
to treba uzeti u obzir u liječenju infekcija uzrokovanih bakterijom h. influenzae.

haemophilus influenzae: s ≤ 0.5 mg/l and r > 0.5 mg/l
haemophilus influenzae: s ≤0,5 mg/l i r >0,5 mg/l

patients less than 18 years of age must be vaccinated against haemophilus influenzae and pneumococcal infections.
bolesnici u dobi manjoj od 18 godina moraju biti cijepljeni protiv bakterije haemophilus influenzae i pneumokoknih infekcija.

haemophilus influenzae type b (hib): can cause brain swelling (inflammation).
haemophilus influenzae tip b (hib): može uzrokovati oticanje (upalu) mozga.

2 conjugated to protein d (derived from non-typeable haemophilus influenzae) carrier protein
2 konjugirani na protein d (proteinski nosač dobiven iz netipiziranog haemophilus influenzae)

hexacima does not protect against infectious diseases caused by other types of haemophilus influenzae or against meningitis of other origins.
hexacima ne štiti od zaraznih bolesti koje su prouzročene drugim tipovima bakterije haemophilus influenzae ili drugim uzročnicima meningitisa.

aerobic gram- negative bacteria haemophilus influenzae$* haemophilus parainfluenzae$ legionella pneumophila moraxella catarrhalis*
aerobne gram-negativne bakterije haemophilus influenzae$* haemophilus parainfluenzae$ legionella pneumophila moraxella catarrhalis

haemophilus influenzae type b polysaccharide 10 micrograms (polyribosylribitol phosphate)3 conjugated to tetanus toxoid as carrier protein approximately 25 micrograms
polisaharid bakterije haemophilus influenzae tip b 10 mikrograma (poliribozilribitolfosfat)3, konjugiran na toksoid tetanusa (proteinski nosač) otprilike 25 mikrograma

hexacima helps to protect against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and serious diseases caused by haemophilus influenzae type b.
hexacima pomaže u zaštiti od difterije, tetanusa, hripavca, hepatitisa b, poliomijelitisa i teških oboljenja prouzročenih bakterijom haemophilus influenzae tip b.

hexacima is a vaccine containing active substances derived from diphtheria, tetanus, pertussis and haemophilus influenzae type b bacteria, the hepatitis b virus, and inactivated polioviruses.
hexacima je cjepivo koje sadrži djelatne tvari dobivene iz difterije, tetanusa, hripavca i bakterije haemophilus influenzae tipa b, virusa hepatitisa b i inaktiviranog poliovirusa.

the main measure of effectiveness was the production of antibody levels known to be protective against diphtheria, tetanus, poliomyelitis, hepatitis b and h. influenzae type b infections and expected to protect against pertussis.
glavna mjera učinkovitosti bila je razina proizvodnje antitijela za koju se zna da štiti od difterije, tetanusa, poliomijelitisa, hepatitisa b i infekcija bakterijom h. influenzae tipa b i za koju se očekuje da štiti od hripavca.

1 adsorbed on aluminium phosphate 0.5 milligram al3+ 2 conjugated to protein d (derived from non-typeable haemophilus influenzae) carrier protein
1 adsorbirani na aluminijev fosfat 0,5 miligrama al3+ 2 konjugirani na protein d, proteinski nosač (dobiven iz netipiziranog haemophilus influenzae)

diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine (adsorbed)
konjugirano cjepivo protiv difterije (d), tetanusa (t), pertusisa (nestanično, komponentno) (pa), hepatitisa b (rdna) (hbv), poliomijelitisa (inaktivirano) (ipv) i haemophilus influenzae tip b (hib) (adsorbirano)